Engerix-b pedi 10 MCG/0.5 syrn 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5V0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,430
Award facts
- Contract value 100% obligated
- $25,429.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 27, 2026, provides for the supply of ENGERIX-B PEDI 10 MCG/0.5 ml syringes—a pediatric hepatitis B vaccine—with a contract ceiling value of $25,429.92. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, under a firm fixed-price delivery order structure with no set-aside designation. The Defense Logistics Agency (DLA), the funding federal agency, utilizes this competitive award mechanism to procure critical medical commodities for military healthcare operations. The place of performance is identified as Conshohocken, Pennsylvania, reflecting the contractor's primary operational location.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The parent entity, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC vehicle, which functions as a comprehensive global pharmaceutical support contract enabling the delivery of a broad range of medications, vaccines, medical devices, and supplies to support military healthcare programs worldwide. The contract completion date of January 28, 2026, reflects the expedited delivery timeline typical of medical supply procurement for active federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FJ5V0?
SPE2DR26FJ5V0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FJ5V0 worth?
The government has obligated $25,430 on SPE2DR26FJ5V0.
Is contract SPE2DR26FJ5V0 an order under another contract?
Yes. SPE2DR26FJ5V0 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5V0 competed?
The extent of competition for SPE2DR26FJ5V0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award